Fara Berkowitz - Free People Check with News, Pictures & Links

	MEDIA Freehold New york

	Investor Relations Chief Financial Officer Director Neothetics Susan Knudson Chief Financial Argot Partners

Images of Fara Berkowitz

(1 - 1 from 1 )

News

(1 - 4 from 22

–show all

)

Cathrine Berkowitz - World News

wn.com

Susan A. Knudson Chief Financial Officer sknudson@neothetics. com Fara Berkowitz, R.Ph, Pharm.D Senior Director, Investor Relations and ...

From Bench to Business: The Commercialization of Science ...

law.duke.edu

Featuring: Dr. Lila W. Hope JD'02, Fara Berkowitz MBA'04, Doug Giordano BSE'84, Jane Henderson AB'87, Donald P. McDonnell, Ph.D., and Jesse Shefferman MBA'07. The event will take place at Pfizer, 235 East 42nd Street, New York NY. Questions? Contact Erica Gavin at .

Lithera Announces Company Name Change to Neothetics, Inc.

www.globenewswire.com

Aug 12, · Neothetics, Inc. Contact: Susan A. Knudson Chief Financial Officer Investor Relations: Fara Berkowitz Argot Partners

Neothetics Announces Top-Line Results for Phase 2 Proof-of ...

www.globenewswire.com

Jun 26, · COMPANY CONTACTS: Susan A. Knudson Chief Financial Officer Fara Berkowitz, R.Ph, Pharm.D Senior Director, Investor Relations and Corporate Development

Telephone & Addresses

(1 - 4 from 5

–show all

)

Fara Berkowitz, New York, US, Duane St, Apt 22C

View Fara's social profiles and photos on Facebook, MySpace, and +40 Networks.

Fara R Berkowitz, 39, Freehold, US, Sycamore Ave

View Fara's social profiles and photos on Facebook, MySpace, and +40 Networks.

Last Name Berkowitz from Ethan to Flo - Advanced Background Checks

www.advancedbackgroundchecks.com

... Faige Berkowitz · Faigy Berkowitz · Faith Berkowitz · Fannie Berkowitz · Fanny Berkowitz · Fara Berkowitz · Fary Berkowitz · Fat Berkowitz · Fawne Berkowitz.

WhitePages: Fara Berkowitz - Phone, Address, Background info | Whitepageswww.whitepages.com › name › Fara-Berkowitz

View phone numbers, addresses, public records, background check reports and possible arrest records for Fara Berkowitz. Whitepages people search is the ...

Network Profiles

Facebook: Search Results for Fara Berkowitz - Facebook

Fara Berkowitz - analyst for sivik

www.skillwho.com

Fara Berkowitz lives in New York City and is a analyst and works for sivik in the Financial Services industry.

Interests

(1 - 4 from 6

–show all

)

Neothetics Provides Business Update and Reports First Quarter

ih.advfn.com

COMPANY CONTACTS: Susan A. Knudson Chief Financial Officer Fara Berkowitz, R.Ph, Pharm.D Senior Director, Investor Relations and Corporate Development

Neothetics Provides Business Update and Reports Third Quarter

www.advfn.com

COMPANY CONTACTS: Fara Berkowitz, R.Ph, Pharm.D Senior Director, Investor Relations and Corporate Development

Neothetics to Release First Quarter Financial Results, Host...

www.advfn.com

... Officer INVESTOR CONTACT: Fara Berkowitz, PharmD Investor Relations and Corporate Strategy ...

Neothetics to Present at Needham & Company's 14th Annual Healthcare...

www.advfn.com

... Financial Officer INVESTOR CONTACT: Fara Berkowitz Investor Relations and Corporate Strategy ...

Management & Stakeholders

Fara Berkowitz - MarketVisual Knowledge Map

www.marketvisual.com

New Search: Fara Berkowitz. Fara Berkowitz. Knowledge Map Preview. Company Affiliations. Search: Company, # of Roles. SIVIK GLOBAL HEALTHCARE LLC ...

Education

classmates: Fara Berkowitz

Freehold Township High School, Freehold, NJ,

Fara R. Berkowitz - Biografie

de.marketscreener.com

Ms. Fara R. Berkowitz is Senior Director-Investor Relations at Neothetics, Inc. Ms. Berkowitz was previously employed as a Managing Director by Meadowvale...

Duke Law Club of New York | Duke University School of Law

law.duke.edu

Featuring: Dr. Lila W. Hope JD'02, Fara Berkowitz MBA'04, Doug Giordano BSE' 84, Jane Henderson AB'87, Donald P. McDonnell, Ph.D., and Jesse Shefferman ...

Reports & Statements

Neothetics Inc(NASDAQ:NEOT) - Pagina 2

www.finanzaonline.com

Titolo molto bastonato dalla delusione del fallimento del trial fase3 a dicembre scorso. qualcosa ho preso verso 0,64, secondo me potrebbe far bene se arrivano...